; (iii) the types of technologies for which technology certification orders were granted; and (iv) the total number of laboratories and developers with technology certification orders in effect. (B) Final report The fifth report submitted under paragraph (1) shall include a summary of, and responses to, comments raised in the meeting and docket. (C) Performance reports The reports required under this section may be issued as a component of performance reports as required under section 9 of the Verifying Accurate Leading-edge IVCT Development Act of 2020 . 587E. Mitigating measures (a) Establishment of mitigating measures (1) Establishing, changing, or withdrawing (A) Establishment If the Secretary determines that the establishment of mitigating measures is necessary for either of the reasons described in clause (i) or (ii) of section 587(15)(A) for any in vitro clinical test with the same indications for use, the Secretary may require that the in vitro clinical test comply with such mitigating measures. (B) Process Notwithstanding subchapter II of chapter 5 of title 5, United States Code, the Secretary may— (i) establish, change, or withdraw mitigating measures by— (I) publishing a proposed administrative order in the Federal Register; (II) providing an opportunity for public comment for a period of not less than 30 calendar days; and (III) after consideration of any comments submitted, publishing a final administrative order in the Federal Register